Cornerstone Advisors’s Amgen AMGN Stock Holding History

Cornerstone Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,300	Closed	-$4.35M	–	104
2025 Q4	$4.35M	Sell	13,300 -18,700	-58%	-$5.93M	0.14%	128
2025 Q3	$9.03M	Sell	32,000 -600	-2%	-$174K	0.3%	83
2025 Q2	$9.1M	Buy	32,600 +5,900	+22%	+$1.67M	0.31%	85
2025 Q1	$8.32M	Hold	26,700	–	–	0.36%	66
2024 Q4	$6.96M	Buy	26,700 +1,300	+5%	+$386K	0.28%	85
2024 Q3	$8.18M	Buy	25,400 +2,500	+11%	+$818K	0.32%	81
2024 Q2	$7.16M	Sell	22,900 -200	-0.9%	-$58.8K	0.29%	88
2024 Q1	$6.57M	Buy	23,100 +300	+1%	+$87.8K	0.27%	99
2023 Q4	$6.57M	Sell	22,800 -1,600	-7%	-$436K	0.29%	88
2023 Q3	$6.56M	Buy	24,400 +3,800	+18%	+$948K	0.31%	84
2023 Q2	$4.57M	Buy	+20,600	New	+$4.78M	0.22%	118
2021 Q4	–	Sell	-17,000	Closed	-$3.62M	–	176
2021 Q3	$3.62M	Hold	17,000	–	–	0.21%	123
2021 Q2	$4.14M	Sell	17,000 -1,000	-6%	-$246K	0.24%	113
2021 Q1	$4.48M	Sell	18,000 -22,000	-55%	-$5.25M	0.39%	70
2020 Q4	$9.2M	Hold	40,000	–	–	0.81%	28
2020 Q3	$10.2M	Buy	40,000 +13,000	+48%	+$3.22M	0.91%	27
2020 Q2	$6.37M	Buy	+27,000	New	+$6.16M	0.59%	40
2019 Q1	–	Sell	-26,000	Closed	-$5.06M	–	197
2018 Q4	$5.06M	Sell	26,000 -20,000	-43%	-$3.9M	0.44%	60
2018 Q3	$9.54M	Hold	46,000	–	–	0.69%	37
2018 Q2	$8.49M	Hold	46,000	–	–	1.03%	28
2018 Q1	$7.84M	Hold	46,000	–	–	0.93%	28
2017 Q4	$8M	Hold	46,000	–	–	0.91%	31
2017 Q3	$8.58M	Buy	46,000 +25,000	+119%	+$4.43M	0.99%	25
2017 Q2	$3.62M	Buy	21,000 +14,000	+200%	+$2.28M	0.66%	41
2017 Q1	$1.15M	Buy	+7,000	New	+$1.16M	0.21%	113
2016 Q4	–	Sell	-14,800	Closed	-$2.47M	–	236
2016 Q3	$2.47M	Sell	14,800 -7,000	-32%	-$1.18M	0.63%	46
2016 Q2	$3.32M	Sell	21,800 -3,000	-12%	-$466K	0.82%	35
2016 Q1	$3.72M	Hold	24,800	–	–	0.9%	30
2015 Q4	$4.03M	Hold	24,800	–	–	0.93%	26
2015 Q3	$3.43M	Buy	24,800 +1,000	+4%	+$158K	0.81%	30
2015 Q2	$3.65M	Hold	23,800	–	–	0.82%	32
2015 Q1	$3.8M	Hold	23,800	–	–	0.79%	34
2014 Q4	$3.79M	Buy	23,800 +8,000	+51%	+$1.25M	0.76%	33
2014 Q3	$2.22M	Hold	15,800	–	–	0.43%	69
2014 Q2	$1.87M	Sell	15,800 -4,000	-20%	-$463K	0.37%	84
2014 Q1	$2.44M	Hold	19,800	–	–	0.57%	52
2013 Q4	$2.26M	Buy	19,800 +6,000	+43%	+$683K	0.56%	52
2013 Q3	$1.54M	Sell	13,800 -4,000	-22%	-$434K	0.5%	56
2013 Q2	$1.76M	Buy	+17,800	New	+$1.85M	0.69%	40

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cornerstone Advisors's AMGN Position: Q1 2026 in Review

Cornerstone Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 13,300 shares — an estimated $4.35M sold.

Cornerstone Advisors first reported a position in AMGN in Q2 2013 and held it in 39 quarters. The position peaked at $10.2M in Q3 2020. 3,138 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Cornerstone Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Cornerstone Advisors sold 13,300 Amgen shares in Q1 2026, an estimated $4.35M.
Cornerstone Advisors first reported a position in Amgen in Q2 2013 and held it in 39 quarters.
Cornerstone Advisors's Amgen position peaked at $10.2M in Q3 2020.
3,138 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cornerstone Advisors's 13F filing for Q1 2026, filed 8 May 2026.